United States · FDA National Drug Code directory

Gralise

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
52427-803_6303a4c5-67f7-9ce7-c655-c87018603b54
Product NDC
52427-803
Form
TABLET, FILM COATED
Composition / generic term
gabapentin
Labeler
Almatica Pharma LLC
Marketing category
NDA
Marketing start / end (source format)
20201001
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 TABLET, FILM COATED in 1 BOTTLE (52427-803-90) · 52427-803-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →